Reply to: “Appropriate use of cholesterol-lowering therapy”

Anne Langsted; Jacob J. Freiberg; Børge G. Nordestgaard

doi:10.1016/j.atherosclerosis.2017.03.017

Reply to: “Appropriate use of cholesterol-lowering therapy”

Anne Langsted, Jacob J. Freiberg, Børge G. Nordestgaard

Department of Clinical Medicine

Original language	English
Journal	Atherosclerosis
Volume	262
Pages (from-to)	200-201
Number of pages	2
ISSN	0021-9150
DOIs	https://doi.org/10.1016/j.atherosclerosis.2017.03.017
Publication status	Published - Jul 2017

Keywords

Cardiovascular disease
Cholesterol
Lipoproteins
Prevention
Statins

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosis.2017.03.017

Cite this

@article{336b7c5d87ca49228196eab7db6c85e2,

title = "Reply to: “Appropriate use of cholesterol-lowering therapy”",

keywords = "Cardiovascular disease, Cholesterol, Lipoproteins, Prevention, Statins",

author = "Anne Langsted and Freiberg, {Jacob J.} and Nordestgaard, {B{\o}rge G.}",

year = "2017",

month = jul,

doi = "10.1016/j.atherosclerosis.2017.03.017",

language = "English",

volume = "262",

pages = "200--201",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Reply to

T2 - “Appropriate use of cholesterol-lowering therapy”

AU - Langsted, Anne

AU - Freiberg, Jacob J.

AU - Nordestgaard, Børge G.

PY - 2017/7

Y1 - 2017/7

KW - Cardiovascular disease

KW - Cholesterol

KW - Lipoproteins

KW - Prevention

KW - Statins

U2 - 10.1016/j.atherosclerosis.2017.03.017

DO - 10.1016/j.atherosclerosis.2017.03.017

M3 - Comment/debate

C2 - 28522146

AN - SCOPUS:85019466512

SN - 0021-9150

VL - 262

SP - 200

EP - 201

JO - Atherosclerosis

JF - Atherosclerosis

ER -